With budgets up yet again, industry marketers are drowning out the political noise and pouncing on the opportunities that present themselves.
MannKind has rebranded for the first time in 20 years as CEO Michael Castagna looks to lead the company’s turnaround.
The digital edition includes features on big data, the Medical Advertising Hall of Fame class of 2020 and rare disease marketing.
Payers spoiled the debut of the first two PCSK9 drugs from Sanofi and Amgen. A third is poised for approval — but if history is any guide, its U.S. market-access path will be anything but smooth.
We analyze three winning rare disease campaigns that illustrate the challenges and opportunities that come with operating in such a difficult realm.
Larry Lesser cofounded Medicus Communications and ApotheCom Associates.
John Kamp was executive director for the Coalition for Healthcare Communication.
Tom Harrison cofounded Harrison & Star.
As part of the Medical Advertising Hall of Fame’s annual awards program, agencies nominate their brightest young stars as Future Famers.
While big tech’s promise to analyze America’s health data has tantalized and terrorized medical marketers, recent developments have pushed many players into a privacy panic.
Please login or register first to view this content.
